Therapeutic Antibodies – News and Features
News
OGeS and Medarex Sign Therapeutic Antibody Collaboration Agreement in Cancer
The collaboration combines OGeS' ability to discover targets for oncology with Medarex's expertise in the development of fully human antibody therapeutics.
News
Immunomedics and IBC Pharmaceuticals Report on a Novel Protein Engineering Platform Technology
The technology may enable the creation of virtually any multifunctional protein for diverse applications.
News
Affitech Renews Worldwide Phage Display License From DKFZ for Breitling Patents
'Breitling' patents hold key position in human antibody discovery field.
News
Amgen Completes Acquisition of Abgenix
Acquisition provides Amgen with full ownership of panitumumab and eliminates a denosumab royalty.
News
CFD Therapeutics Formed to Advance Monoclonal Antibodies for Cancer
diaDexus provided an exclusive license to CFD for its entire portfolio of therapeutic targets and associated monoclonal antibodies.
News
Demonstration of Therapeutic Gene Silencing in Primates with Systemic RNAi Published in Nature
Systemic RNAi shown to have durable effect and feasible dosage for future human clinical studies.
News
BioWa Licenses POTELLIGENT™ Technology to Genentech
BioWa licenses the technology for use in researching and developing select Genentech antibodies.
News
MorphoSys and Daiichi Sankyo Form Broad Alliance
Both Companies have entered into a license agreement and therapeutic antibody collaboration.
News
MorphoSys and Roche Expand Therapeutic Antibody Partnership
Roche and MorphoSys will collaborate on two new antibody programs in oncology.
News
MorphoSys Achieves Fourth Therapeutic Milestone in Centocor Collaboration
MorphoSys developed fully human IgG antibodies using its HuCAL GOLD® antibody library against a Centocor target.
Advertisement
